FHA
HQL

Flagship Harbor Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Flagship Harbor Advisors’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.23M Buy
382,717
+19,336
+5% +$323K 0.27% 90
2025
Q4 		$6.1M Buy
363,381
+6,257
+2% +$105K 0.29% 82
2025
Q3 		$5.54M Buy
357,124
+15,165
+4% +$208K 0.24% 95
2025
Q2 		$4.38M Buy
341,959
+1,082
+0.3% +$13.3K 0.21% 113
2025
Q1 		$4.33M Buy
340,877
+90,436
+36% +$1.22M 0.23% 97
2024
Q4 		$3.29M Sell
250,441
-62,502
-20% -$902K 0.17% 117
2024
Q3 		$4.72M Buy
312,943
+10,603
+4% +$160K 0.26% 85
2024
Q2 		$4.28M Buy
302,340
+18,511
+7% +$250K 0.26% 88
2024
Q1 		$3.87M Buy
283,829
+19,826
+8% +$274K 0.25% 90
2023
Q4 		$3.55M Buy
264,003
+32,545
+14% +$400K 0.26% 84
2023
Q3 		$2.89M Buy
231,458
+207
+0.1% +$2.72K 0.24% 97
2023
Q2 		$3.13M Sell
231,251
-135,868
-37% -$1.87M 0.26% 91
2023
Q1 		$5.11M Sell
367,119
-366
-0.1% -$5.23K 0.48% 47
2022
Q4 		$5.22M Buy
367,485
+11,802
+3% +$171K 0.54% 39
2022
Q3 		$4.86M Buy
355,683
+9,986
+3% +$149K 0.56% 36
2022
Q2 		$4.92M Buy
345,697
+6,514
+2% +$98.4K 0.55% 36
2022
Q1 		$5.61M Buy
339,183
+4,454
+1% +$76.7K 0.54% 35
2021
Q4 		$6.44M Buy
334,729
+10,494
+3% +$211K 0.61% 28
2021
Q3 		$6.95M Hold
324,235
– – 0.75% 22
2021
Q2 		$6.95M Buy
324,235
+1,922
+0.6% +$38.8K 0.75% 22
2021
Q1 		$6.35M Buy
322,313
+17,836
+6% +$368K 0.72% 20
2020
Q4 		$6.01M Buy
304,477
+11,082
+4% +$205K 0.75% 19
2020
Q3 		$5.16M Buy
293,395
+8,235
+3% +$147K 0.7% 20
2020
Q2 		$5.12M Buy
285,160
+7,616
+3% +$131K 0.75% 19
2020
Q1 		$4.16M Buy
277,544
+844
+0.3% +$13.8K 0.83% 20
2019
Q4 		$4.82M Sell
276,700
-4,893
-2% -$80.3K 0.84% 17
2019
Q3 		$4.25M Buy
281,593
+6,920
+3% +$111K 0.83% 17
2019
Q2 		$4.63M Buy
274,673
+6,854
+3% +$113K 0.96% 13
2019
Q1 		$4.59M Buy
267,819
+13,559
+5% +$234K 0.94% 13
2018
Q4 		$3.84M Buy
254,260
+4,938
+2% +$87K 0.93% 15
2018
Q3 		$5.07M Buy
249,322
+1,248
+0.5% +$24.8K 0.94% 10
2018
Q2 		$4.66M Buy
248,074
+16,842
+7% +$317K 0.93% 11
2018
Q1 		$4.26M Buy
231,232
+20,912
+10% +$419K 1.27% 7
2017
Q4 		$4.18M Buy
210,320
+9,059
+5% +$181K 1.2% 10
2017
Q3 		$4.44M Buy
201,261
+9,152
+5% +$194K 1.44% 10
2017
Q2 		$4.02M Buy
192,109
+13,740
+8% +$278K 1.4% 7
2017
Q1 		$3.44M Buy
178,369
+13,715
+8% +$254K 1.31% 8
2016
Q4 		$2.91M Buy
+164,654
New +$2.89M 1.26% 9

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Flagship Harbor Advisors's HQL Position: Q1 2026 in Review

Flagship Harbor Advisors increased its abrdn Life Sciences Investors (HQL) stake by 5.3% in Q1 2026, buying an estimated $323K and bringing the position to 382,717 shares worth $6.23M. The position accounts for 0.27% of the portfolio, ranked #90.

Flagship Harbor Advisors first reported a position in HQL in Q4 2016 and has held it in 38 quarters since. The position peaked at $6.95M in Q3 2021. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Flagship Harbor Advisors held 382,717 shares of abrdn Life Sciences Investors worth $6.23M as of Q1 2026.
  • Flagship Harbor Advisors bought 19,336 abrdn Life Sciences Investors shares in Q1 2026, an estimated $323K.
  • abrdn Life Sciences Investors made up 0.27% of Flagship Harbor Advisors's portfolio in Q1 2026, its #90 holding.
  • Flagship Harbor Advisors first reported a position in abrdn Life Sciences Investors in Q4 2016 and has held it in 38 quarters since.
  • Flagship Harbor Advisors's abrdn Life Sciences Investors position peaked at $6.95M in Q3 2021.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.